Latest filing published 26 Apr 2021 for NeuroPace Inc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -70.6%Entry US$26.20 · Close at T+365 US$7.69
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Greg Shaw Garfield: trading record in brief
All filings by Greg Shaw Garfield on record concern NeuroPace Inc. Between 21 April 2021 and 26 April 2021, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €187k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 26 April 2021, the filings show a transaction in NeuroPace Inc. The last insider purchase was made public on 23 April 2021, 2,026 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Greg Shaw Garfield
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,891 shares0Common StockSEC:0001209191-21-028325:0
- 5,595,493 shares0Common StockSEC:0001209191-21-028325:1
- 13,235 shares@ US$17.00100.0% of flowCommon StockSEC:0001209191-21-028189:0Canonical exit: 20 Jul 2021 (T+90)
3 of 3 declarations
